Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis by Cherubini, Marta et al.
Contents lists available at ScienceDirect
Neurobiology of Disease
journal homepage: www.elsevier.com/locate/ynbdi
Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-
mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive
Oxygen Species (ROS) homeostasis
Marta Cherubinia,b,c,1, Laura Lopez-Molinaa,b,c,1, Silvia Ginesa,b,c,⁎
a Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain
b Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
c Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain








A B S T R A C T
Mitochondria-associated membranes (MAMs) are dynamic structures that communicate endoplasmic reticulum
(ER) and mitochondria allowing calcium transfer between these two organelles. Since calcium dysregulation is
an important hallmark of several neurodegenerative diseases, disruption of MAMs has been speculated to
contribute to pathological features associated with these neurodegenerative processes. In Huntington's disease
(HD), mutant huntingtin induces the selective loss of medium spiny neurons within the striatum. The cause of
this specific susceptibility remain unclear. However, defects on mitochondrial dynamics and bioenergetics have
been proposed as critical contributors, causing accumulation of fragmented mitochondria and subsequent Ca2+
homeostasis alterations. In the present work, we show that aberrant Drp1-mediated mitochondrial fragmenta-
tion within the striatum of HD mutant mice, forces mitochondria to place far away from the ER disrupting the
ER-mitochondria association and therefore causing drawbacks in Ca2+ efflux and an excessive production of
mitochondria superoxide species. Accordingly, inhibition of Drp1 activity by Mdivi-1 treatment restored ER-
mitochondria contacts, mitochondria dysfunction and Ca2+ homeostasis.
In sum, our results give new insight on how defects on mitochondria dynamics may contribute to striatal
vulnerability in HD and highlights MAMs dysfunction as an important factor involved in HD striatal pathology.
1. Introduction
Mitochondria are dynamic organelles that provide energy to cells
and buffer intracellular calcium (Ca2+). In neurons, which critically
depend on mitochondria function due to their high-energy demands,
mitochondria can travel from the soma to dendritic and axonal pro-
cesses to supply local necessities of Adenosine triphosphate (ATP) and
Ca2+ maintenance. To ensure a proper distribution, mitochondria dy-
namically undergo shape changes modulated through regulated fission
and fusion events (Frederick and Shaw, 2007; Campello and Scorrano,
2010).
Mitochondria are not isolated structures but interact with other
organelles. The best characterized inter-organelle crosstalk is between
mitochondria and endoplasmic reticulum (ER). These contact sites
called mitochondria-associated membranes (MAMs) are specialized re-
gions that act as a signaling hub to regulate cellular Ca2+ homeostasis
(Rusiñol et al., 1994; Rizzuto et al., 1998; Csordás et al., 2006). Indeed,
it has been reported that ER releases calcium in this specialized mem-
brane hotspots directed towards mitochondria in order to maintain
cellular bioenergetics and mitochondrial dynamics and therefore, cel-
lular lifespan (Szabadkai et al., 2006; Rowland and Voeltz, 2012).
These contact sites are characterized by a proteome enriched in
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proteins involved in MAMs function. Thus, the Ca2+ channel inositol-
1,4,5-triphosphate (IP3) receptor (IP3R) in the ER associates with the
protein voltage-dependent anion channel isoform 1 (VDAC1) in the
outer mitochondrial membrane. This interaction is strengthened
through the molecular chaperone glucose-regulated protein 75 (GRP75)
and the mitochondrial protein mitofusin-2 (Mfn2) allowing an efficient
efflux of Ca2+ (Szabadkai et al., 2006; De Brito and Scorrano, 2008;
Mendes et al., 2005). In this scenario, it is not surprising that either
upregulation or disruption of ER-mitochondria contacts will be pre-
dicted of neuronal dysfunction and cell death distinctive of several
neurodegenerative disorders (Calì et al., 2013a). Indeed, alterations in
MAMs-related proteins have been reported in Alzheimer's disease
(Area-Gomez et al., 2012; Hedskog et al., 2013), Parkinson's disease
(Calì et al., 2013b; Ottolini et al., 2013) and Amyotrophic lateral
sclerosis (Stoica et al., 2014). However, no evidence of ER-mitochon-
dria contact alterations have been demonstrated in Huntington's dis-
eases (HD). HD is an autosomal dominant neurodegenerative disorder
characterized by a classic triad of symptoms consistent on movement
disorders, psychiatric disturbances and cognitive decline (Huntington,
1872; Ross and Margolis, 2001). Mutant huntingtin (mHtt) causes the
preferential degeneration of medium spiny neurons within the striatum
(Vonsattel et al., 1985) that expands to other brain regions throughout
the disease (Vonsattel and DiFiglia, 1998). The mechanism of this se-
lective neuronal dysfunction and death remains elusive. Though several
pathologic processes have been proposed, strong evidence from studies
in humans and animal models suggests the involvement of mitochon-
drial dysfunction (Panov et al., 2002; Orr et al., 2008). Thus, indicators
of mitochondrial defects including decreased ATP and free radical
production, respiratory complex inhibition, loss of mitochondrial
membrane potential and Ca2+ buffering disturbances have been re-
cognized in HD (Giacomello et al., 2011; Reddy, 2014). In this line,
previous studies from our group and others have demonstrated that
mitochondrial fusion and fission are significantly perturbed and im-
balanced in HD leading to accumulation of fragmented and damaged
mitochondria with the subsequent increase in oxidative stress and en-
ergy defects (Cherubini et al., 2015; Shirendeb et al., 2011; Song et al.,
2011). Though the precise mechanisms underlying excessive mi-
tochondrial fragmentation in HD are not clear, it has been suggested
that mHtt could induce Drp1 activity by direct interaction (Song et al.,
2011; Shirendeb et al., 2012) or modulation of Drp1 S-nitrosylation
levels (Nakamura et al., 2013). Accordingly, mutant huntingtin-in-
duced-mitochondria and synaptic damage can be prevented by phar-
macological inhibition of Drp1 activity by Mdivi-1 (Manczak and
Hemachandra Reddy, 2015).
With all these evidences, in this work, we sought to analyze whether
proneness of HD striatal mitochondria to undergo fragmentation could
result in loss of ER-mitochondria contacts, and therefore, disruption of
the correct Ca2+ buffering by the mitochondria. We postulate that this
disruption, would contribute to Ca2+ dyshomeostasis increasing HD
striatal vulnerability.
2. Materials and methods
2.1. Mice
R6/1 heterozygous transgenic mice (B6CBA background) expressing
the exon-1 of mhtt with 145 CAG repeats. Our R6/1 mice colony ex-
presses 145 CAG repeats instead of 115 CAG repeats of the original R6/
1 mice due to CAG repeat instability as has been previously described
by other groups (Morton et al., 2009; Møllersen et al., 2010). Hetero-
zygous mutant HdhQ7/Q111 knock-in mutant mice, with targeted inser-
tion of 109 CAG repeats that extends the glutamine segment in murine
huntingtin to 111 residues and wild type HdhQ7/Q7 mice, were main-
tained on a C57BL/6 genetic background. Female HdhQ7/Q7 mice were
crossed with male HdhQ7/Q111 mice to generate age-matched HdhQ7/Q7
wild type (WT) and HdhQ7/Q111 (Hdh+/Q111) littermates, determined by
Polymerase Chain Reaction (PCR) analysis. Mice were housed with
access to food and water ad libitum in a colony room kept at 19–22 °C,
under a 12:12 h light/dark cycle. All mice used in the present study
were males and were housed together in numerical birth order in
groups of mixed genotypes. All procedures involving animals were
performed in compliance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals, and approved by the local
animal care committee of the Universitat de Barcelona (99/01) and
Generalitat de Catalunya (99/1094), in accordance with the European
(2010/63/EU) and Spanish (RD53/2013) regulations for the care and
use of laboratory animals.
2.2. Primary neuronal cultures
Dissociated striatal, cortical and hippocampal primary cultures
prepared from E17.5 wild type (WT) and R6/1 embryos were plated at a
density of 40,000 or 80,000 neurons for immunocytochemistry and
transfections respectively, onto 12mm coverslips placed in 24-well
plates or at a density of 80–90,000 neurons onto 25mm coverslips pre-
coated with 0.1 mg/ml poly-D-lysine (Sigma Chemical Co., St. Louis,
MO) placed in 6-well plates for calcium analysis. Neurons were cultured
in Neurobasal medium (Gibco-BRL, Renfrewshire, Scotland, UK) sup-
plemented with Glutamax and B27 (Gibco-BRL). Cultures were main-
tained at 37 °C in a humidified atmosphere containing 5% CO2. All
experiments with neuronal cultures were analyzed 14 days after plating
(DIV 14).
2.3. Plasmids and cell transfection
Fluorescent labelling of mitochondria and endoplasmic reticulum
was achieved transfecting primary striatal neurons with pDsRed2-Mito
and GFP-Sec61-β constructs, respectively. The pDsRed2-Mito vector
(Clontech Laboratories; no. 632421) encodes a fusion of Discosoma sp.
red fluorescent protein (DsRed2) and a mitochondrial targeting se-
quence of human cytochrome c oxidase subunit VIII (Mito). The GFP-
Sec61-β vector, expressing the ER membrane protein Sec61β tagged
with the green-fluorescent protein (GFP), was kindly supplied by Dr.
Rapoport through the Addgene platform (Addgene; no. 15108).
Primary neurons were transfected with Neuromag as instructed by the
manufacturer (OZ Biosciences, France). Striatal primary neurons were
transfected with 1 μg of both plasmids at DIV 10, fixed with 4% PFA/
phosphate buffer and then analyzed at DIV 14.
2.4. Drug treatment
To assess the effect of dynamin-related protein 1 (Drp1) inhibition
on mitochondrial dynamics and function, primary striatal neurons at
DIV 14, were exposed to 25 μM of Mitochondrial division inhibitor 1
(Mdivi-1; Sigma Chemical Co., St. Louis, MO) for 1 h. Vehicle group was
treated with 25 μM of dimethyl sulfoxide (DMSO). After treatment, cells
were fixed with 4% paraformaldehyde (PFA)/phosphate buffer for
immunocytochemistry analysis or prepared for calcium measurement
assays.
2.5. Immunocytochemistry
For immunocytochemistry analysis, neurons were fixed at DIV 14
with 4% PFA/phosphate buffer for 10min, rinsed in phosphate buffered
saline (PBS), blocked in PBS containing 0.1M glycine for 10min, per-
meabilized in PBS containing 0.1% saponin for 10min and finally
blocked in PBS containing Normal Horse Serum 15% for 30min at room
temperature. Neurons were then washed in PBS and incubated over-
night at 4 °C with primary antibody Microtubule-associated protein 2
(MAP2) (1:500, Sigma-Aldrich) or TOM-20 (1:250, ProteinTech) and
detected with AlexaFluo488 anti-mouse (1:100, Jackson
InmunoResearch), AlexaFluo488 anti-rabbit (1:100, Jackson
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InmunoResearch), Cy3 anti-rabbit (1:100, Jacson InmunoResearch) or
Cy3 anti-mouse (1:100, Jacson InmunoResearch).
2.6. Confocal images acquisition
Immunofluorescence was analyzed by confocal microscopy using a
Leica TCS SP5 laser scanning confocal microscope (Leica Microsystems
CMS GmbH, Germany). Images were taken using a HCX PL APO lambda
blue 63.0×1.40 OIL objective with a standard pinhole (1 AU). For
each image, z-stacks were taken from the entire three-dimensional
structure. Digital zoom and size of stack depended on the experiment.
2.7. Analysis of mitochondria morphology
Mitochondrial morphology was analyzed as previously described
(Cherubini et al., 2015; Koopman et al., 2006). Briefly, for quantitative
analysis, digital images with 3.0 digital zoom and stacks of 0.4 μm were
processed through a convolve filter and automatically thresholded
using ImageJ software. From binary image, individual mitochondria
were subjected to particle analyses to obtain number of mitochondria
per cell, Aspect Ratio (AR, length-to-width ratio), and Form Factor (FF,
(Pm2/4 π×Am), where Pm is the perimeter and Am is the surface area
of mitochondrion. AR values of 1 mean a perfect circle, and the higher
AR, the more elongated mitochondria. FF values of 1 indicate un-
branched mitochondrion, and higher FF correspond to more complex
mitochondria network. For each condition, 10–15 neurons were ana-
lyzed from 6 to 8 independent experiments.
2.8. ER-mitochondria co-localization analysis
For endoplasmic reticulum (ER)-mitochondria contact sites analysis,
digital images were taking with 4.0 digital zoom and stacks of 0.2 μm.
Stacks were automatically thresholded, deconvolved and the back-
ground was subtracted using ImageJ software. Interactions between
organelles were quantified through Mander's co-localization coeffi-
cients obtained from ImageJ plugin “JACop”. For each condition, 10–15
neurons were analyzed from 5 to 9 independent experiments.
2.9. Analysis of ER-mitochondria contacts by proximity ligation assay
(PLA)
Proximity ligation assay (PLA) was performed using Duolink® de-
tection kit with red fluorophore λ excitation 594 nm/λ emission
624 nm. After fixation and blocking, cells were first incubated with
MAP2 (1:500, Sigma-Aldrich) to stain neurites in striatal neurons and
then with primary antibodies IP3R3 (1:500, Merck, Germany) and
VDAC1 (1:500, Abcam, UK) overnight. After washing with PBS, PLA
probes anti-mouse PLUS and anti-rabbit MINUS were added for 1 h and
hybridization was amplified by rolling circle amplification. Nuclei were
stained with 4 ‘6-diamidino-2-fenilindol (DAPI) using mounting media
provided in the kit. Digital images were taking with 3.0 digital zoom
and stacks of 0.4 μm. Fluorescent dots were analyzed using the plugin
“Analyze particles” of ImageJ. Number of particles were relativized to
MAP2 area of interest. As a negative control, one of the primary anti-
bodies was omitted.
2.10. Mitochondrial superoxide production
To evaluate mitochondrial superoxide production in cultures,
striatal primary neurons at DIV 14 were incubated with MitoSOX™ Red
Indicator (Molecular Probes, Invitrogen) for 30min at 37 °C. Cells were
then fixed with 4% PFA/phosphate buffer and nuclei stained with DAPI.
Digital images with 4.0 digital zoom and stacks of 0.4 μm were pro-
cessed through a convolve filter, background was subtracted and au-
tomatically thresholded using ImageJ software. MitoSOX intensity was
calculated as Integrated Density/Area of cell. For each condition, 15
neurons were analyzed from 7 to 8 independent experiments.
2.11. Western blot analysis
Animals were sacrificed by cervical dislocation and striatum, hip-
pocampus, and cortex were dissected. Tissue was homogenized by so-
nication in lysis buffer (50mM Tris base, pH 7.5, 10mM EGTA, 150mM
NaCl, protease inhibitor mixture and 1mM sodium orthovanadate) and
centrifuged at 10,000×g for 10min. Supernatant was collected and
protein content was measured by Detergent-Compatible Protein Assay
(Bio-Rad, Hercules, CA, USA). Protein extracts (20 μg) were denatured
in 62.5mM Tris-HCl (pH 6.8) 2% SDS, 10% glycerol, 140mM β-mer-
captoethanol and boiled for 5min. Protein samples were resolved on
6–10% SDS-PAGE and transferred onto nitrocellulose membranes. Blots
were blocked with 10% non-fat powdered milk in Tris-buffered saline
Tween-20 (TBS-T) for 1 h at room temperature. Membranes were in-
cubated overnight at 4 °C with primary antibodies: Drp1 (DLP1; 1:1000;
BD Bioscience), Grp75 (1:2000, Abcam), IP3R3 (1:500, BD), Mfn2
(1:2000, Abcam), Calnexin (1:1000, Santa Cruz), Calreticulin (1:1000,
Santa Cruz), Nogo (1:1000, Santa Cruz), and Stim1 (1:1000, Santa
Cruz). For protein loading control, membranes were incubated 20min
with an antibody against α-tubulin (1:50,000, Sigma Aldrich). After
primary antibody incubation, membranes were rinsed three times for
10min with TBS-T and incubated for 1 h at room temperature with a
horseradish peroxidase-conjugated secondary antibody (1:3000,
Promega). Inmunoreactive bands were visualized using ECL kit (Santa
Cruz) and quantified by using Image J software.
2.12. Calcium measurement
To detect cytosolic Ca2+ changes (Cai2+), wild type and R6/1 pri-
mary striatal neurons, cultured on glass coverslips during 14 days (DIV
14), were washed with Krebs buffer (145mM NaCl, 5 mM KCl, 10mM
HEPES, 1mM MgCl2, 1 mM CaCl2, 5.6mM glucose and pH 7.4/NaOH)
and loaded with 5 μm Fluo-4 AM/0.02% Pluronic F-127 (Molecular
Probes, Invitrogen) at room temperature in the dark for 30min. After
rinsing with fresh buffer, cells were loaded with 20 nM tetra-
methylrhodamine methyl ester (TMRM; Molecular Probes, Invitrogen)
at room temperature in the dark for 20min in order to detect changes in
mitochondrial membrane potential (ΔΨm). Cells were then washed and
Fig. 1. R6/1 primary striatal neurons exhibit increased Drp1-dependent mitochondrial fragmentation. (A) Representative confocal images of striatal primary neurons
from WT and R6/1 mice in basal conditions. Neurons were transfected with pDsRed2-mito in red and labelled with anti-MAP2 in green. Scale bar 20 μm. The boxed
areas are enlarged in the right panels. Bar histograms show the percentage of mitochondria per axonal micron, the percentage of cells with fragmented mitochondria,
the relative Aspect Ratio and the relative Form Factor. Data represent mean ± SEM of 6–8 independent experiments with 10–15 neurons/genotype each. ⁎⁎p < .01,
⁎⁎⁎p < .001, ⁎⁎⁎⁎p < .0001 vs WT as determined by unpaired Mann-Whitney test or Kruskal-Wallis test with Dunn's post hoc analysis. (B) Representative confocal
images of striatal primary neurons fromWT and R6/1 mice treated with vehicle (DMSO) or Mdivi-1 (25 μM). Bar histograms show the percentage of mitochondria per
axonal micron, the relative Aspect Ratio and the relative Form Factor. Data represent mean ± SEM of 6–8 independent experiments with 10–15 neurons/genotype
each. ⁎p < .05, ⁎⁎⁎⁎p < .0001 vs WT; ###p < .001 vs R6/1 DMSO as determined by unpaired Mann-Whitney test or Kruskal-Wallis test with Dunn's post hoc
analysis. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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coverslips were assembled in a chamber filled with 500 μl of buffer
containing TMRM on the stage of the Leica confocal microscope
equipped with an incubation system with temperature and CO2 control.
After a 5min equilibration time, neurons were exposed to 0.5 μM
Thapsigargin (TG; Sigma-Aldrich), a SERCA ATPase inhibitor that in-
creases the concentration of intracellular Ca2+ by blocking its storage
in the ER. Simultaneously, TMRM was excited at 543 nm and the
emission collected with a 560 nm long-pass filter, and Fluo-4 was ex-
cited at 488 nm and the emission collected through a 505–550 nm
barrier filter. Experiments were terminated inducing a maximal mi-
tochondrial depolarization by addition of 2 μM Carbonyl cyanide 4-
(trifluoromethoxy) phenylhydrazone (FCCP; Sigma-Aldrich), an un-
coupler of respiratory chain oxidative phosphorylation that depolarizes
mitochondrial membrane determining Ca2+ release into the cytosol.
Images were captured every 2 s throughout about 8–10min of experi-
ment. The quantification of fluorescence intensities was calculated
using ImageJ software and the values were normalized to the baseline
images. Fluo 4 and TMRM fluorescence changes are showed as fold
change of normalized response F/F0 where F0 is the fluorescence in-
tensity at time zero; F is the corrected fluorescence intensity at a given
time point.
2.13. Subcellular fractionation
Microsomal fractions were obtained as described in Bozidis et al.
(2007). Briefly, striata from three different mice (wild type or R6/1)
Fig. 2. ER-mitochondria contacts are diminished in R6/1 primary striatal neurons. (A) Representative confocal images of striatal primary neurons from WT and R6/1
mice transfected with GFP-Sec61-β in green and pDsRed2-mito in red. Scale bar 20 μm. Panels on the right show single and merged channels magnifications of the
boxed areas. Bar histogram shows normalized Mander's coefficient values calculated from z-axis confocal stacks. Data represent mean ± SEM of 9 independent
experiments with 10–15 neurons/genotype each. ⁎⁎⁎⁎p < .0001 vs WT as determined by unpaired Mann-Whitney test. (B) Representative confocal images of VDAC1/
IP3R3 interaction by in situ PLA in striatal primary neurons. Nuclei appear in blue, interactions between the two targeted proteins in red, and anti-MAP2 in green.
Scale bar 20 μm. Bar histogram shows number of particles/total area. Data represent mean ± SEM of 8 independent experiments in which 20 neurons were
examined per genotype using ImageJ software. ⁎⁎⁎⁎p < .0001 as determined by unpaired Mann-Whitney test. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
Fig. 3. Inhibition of mitochondria fission by Mdivi-1 recovers ER-mitochondria contact sites in R6/1 primary striatal neurons. Representative confocal images of
striatal primary neurons from WT and R6/1 mice. Neurons were transfected with GFP-Sec61-β in green and pDsRed2-mito in red. Scale bar 50 μm. Panels on the right
show single and merged channels magnifications of the boxed areas. Bar histogram shows normalized Mander's coefficient values calculated from z-axis confocal
stacks. Data represent mean ± SEM of 5–6 independent experiments with 10 neurons/genotype each. ⁎⁎⁎⁎p < .0001 vs WT; ####p < .0001 vs R6/1 DMSO as
determined by unpaired Mann-Whitney test or Kruskal-Wallis test with Dunn's post hoc analysis. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
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Fig. 4. Excessive mitochondrial superoxide production in R6/1 striatal primary neurons is normalized after Mdivi-1 treatment. Representative confocal images of
striatal primary neurons from WT and R6/1 mice treated with vehicle (DMSO) or Mdivi-1 (25 μM). Mitochondrial superoxide production was determined using
MitoSOX Red Indicator. Nuclei appear in blue. Scale bar 20 μm. Bar histogram shows intensity of MitoSOX per cell area. Data represent mean ± SEM of 7–8
independent experiments with 15 neurons/genotype each. ⁎⁎⁎⁎p < .0001 vs WT, ####p < .0001 vs R6/1 DMSO as determined by Kruskal-Wallis test with Dunn's
post hoc analysis. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 5. Decrease of MAM proteins in the striatum of both R6/1 and HdhQ7/Q111 mutant mice. (A) Representative Western Blots showing the levels of Grp75, IP3R3,
and Mfn2 in the striatum of WT and R6/1 mice at different disease stages (W, weeks; n=6–7 animals). α-tubulin was used as a loading control. Histograms show
relative protein levels in R6/1 mice expressed as percentage of WT mice. Data represent mean ± SEM. ⁎p < .05, ⁎⁎⁎p < .001 vs WT as determined by unpaired
Student's t-test. (B) Representative Western Blots showing the levels of Grp75, IP3R3, and Mfn2 in the striatum of wild type HdhQ7/Q7 and mutant HdhQ7/Q111 mice at
different disease stages (M, months; n=6–7 animals). α-tubulin was used as a loading control. Histograms show relative protein levels in HdhQ7/Q111 mice expressed
as percentage of WT mice. Data represent mean ± SEM. ⁎p < .05 vs WT as determined by unpaired Student's t-test.
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were pooled and homogenized with a dounce homogenizer in sucrose
homogenization medium (0.25M sucrose, 10mM HEPES, pH 7.4).
Samples were then centrifuged twice at 4 °C for 5min at 600×g and
supernatant further centrifuged four times at 4 °C for 10min at
10,300×g. The resultant supernatant was next ultracentrifuged at 4 °C
for 60min at 100,000×g to pellet microsomes. Finally, the resultant
microsomal fraction containing rough and smooth ER was resuspended
in sucrose homogenization medium.
2.14. Statistical analysis
All the results were analyzed using GraphPad Prism software ver-
sion 7.0. Data were presented as mean ± standard error of the means
(SEM). Statistical analysis was performed using Student's t-test or
Mann-Whitney test for two groups and Kruskal-Wallis followed by the
post hoc Dunn's test for multiple comparison. Differences were con-
sidered statistically significant when p value< .05.
3. Results
3.1. Increased Drp1-dependent mitochondrial fragmentation in R6/1
striatal cultures
Excessive Drp1-mediated mitochondrial fission has been reported in
R6/2 striatum as well as in other neuronal primary cultures over-
expressing exon-1 with a HD polyQ expansion (Song et al., 2011; Guo
et al., 2013). However, no data regarding mitochondrial morphology
has been described in the striatum of R6/1 mice. Therefore, mi-
tochondrial network was analyzed in striatal cultures from WT and R6/
1 mice at DIV 14 transfected with pDsRed2-Mito and stained with MAP-
2 for neurites (Fig. 1A). Morphometric analysis by confocal microscopy
revealed higher mitochondrial fission in mutant R6/1 striatal cultures
compared with WT cultures, as evidenced by a significant increase in
the number of mitochondria within neuritic projections or a trend in-
crease in the number of cells showing fragmented mitochondria
(Fig. 1A). Accordingly, a significant reduction of mitochondrial length
(Aspect Ratio; Fig. 1A) and mitochondrial complexity with decreased
branching (Form Factor; Fig. 1A) was observed in mutant R6/1 striatal
neurons. Notice the presence of donut-shape mitochondria in R6/1
striatal cultures likely related to mitochondrial oxidative stress (Ahmad
et al., 2013). To assess whether changes in mitochondria dynamics
were specific of the striatal brain area, mitochondria morphology was
also evaluated in cortical (Fig. S1A) and hippocampal primary cultures
(Fig. S1B). No significant differences between genotypes were found
neither in cortical nor in hippocampal primary cultures, pointing the
striatum as the most vulnerable region to mitochondria pathology in
HD.
Drp1 increased activity has been proposed as a potential mechanism
underlying mitochondrial fission in HD (Shirendeb et al., 2012; Costa
et al., 2010). To test this possibility in our R6/1 striatal cultures, neu-
ronal cells were incubated with Mdivi-1 (25 μM, 1 h), a well-known
chemical inhibitor of the mitochondrial fission protein Drp1 (Cassidy-
Stone et al., 2008) and mitochondrial network was analyzed (Fig. 1B).
Treatment with Mdivi-1 was able to prevent mitochondrial fragmen-
tation, showing R6/1 treated neurons values of mitochondria number,
length and branching similar to those in WT vehicle cultures (Fig. 1B).
According with these findings, Western blot analysis in R6/1 striatal
primary cultures, demonstrated a trend increase in Drp1 tetrameric
(~320 kDa) but not monomeric forms (~80 kDa) when compared with
WT striatal cells (Fig. S2A). Notice that, Drp1 oligomerization has been
associated, at least in part, with Drp1 activation (Guo et al., 2013; Cho
et al., 2014; Zhu et al., 2004). Similarly, when Drp1 mRNA levels were
evaluated a great increase, though not significant, in R6/1 versus WT
striatal neuronal cells was found (Fig. S2B) All these findings demon-
strate excessive mitochondrial fragmentation in R6/1 mutant striatal
neurons that is dependent on Drp1 activity.
3.2. Diminished ER-mitochondria contact sites in R6/1 striatal cultures
Contacts between the ER and mitochondria at MAMs represent a
critical intracellular signaling platform that regulates different and
crucial cellular functions (Raturi and Simmen, 2013; Iwasawa et al.,
2011). Given the increase in mitochondrial fission observed in R6/1
striatal cultures, we wondered whether disrupted mitochondrial net-
work could also impair ER-mitochondria association. To this aim, WT
and R6/1 striatal neurons (DIV 14) were transfected with GFP-Sec61β
Fig. 6. MAM proteins are also reduced in putamen postmortem samples from HD patients. Representative Western Blots showing the levels of Grp75, IP3R3 and Mfn2
in post-mortem putamen samples from control (n=6) and HD patients (n=8). α-tubulin was used as a loading control. Histograms show relative protein levels in
HD samples expressed as percentage of control samples. Data represent mean ± SEM. ⁎p < .05, ⁎⁎p < .01 vs control as determined by unpaired Student's t-test.
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and pDsRed2-Mito to label ER and mitochondria respectively and co-
localization studies were performed by using confocal microscopy
(Fig. 2A). Analysis of immunofluorescence images revealed that a
proportion of Sec61β overlapped with pDsRed2-Mito in both WT and
R6/1 neurons, indicating ER-mitochondria association (Fig. 2A).
However, co-localization levels were significantly lower in R6/1 striatal
neurons compared with WT neurons as supported by the calculation of
the Manders'colocalization coefficient, which suggest a significant de-
crease in ER-mitochondria contact sites in R6/1 (Fig. 2A). To further
elaborate on these findings, we sought to use proximity ligation assays
(PLA) to quantify the profusion of ER-mitochondria associations in WT
and R6/1 striatal cultures (Fig. 2B). For these assays, we used VDAC1
and IP3R3 primary antibodies as probes for mitochondria and ER re-
spectively, since these proteins are enriched at MAMs (Hedskog et al.,
2013). MAP2 staining was used to determine neurite area and used to
normalize PLA values. Negative controls showed no signal (Fig. S3A).
Consistent with confocal analysis, the abundance of ER-mitochondria
contact sites, measured as interaction between VDAC1 and IP3R3 (PLA
puncta) was found to be lower in R6/1 compared to WT striatal neurons
(Fig. 2B). Since reduced PLA signal can be due to lower expression of
VDAC1 and/or IP3R3, we next determined the levels of both proteins in
lysates from WT and R6/1 striatal cultures by Western blot analysis
(Fig. S3B). No significant differences between genotypes were found
either for VDAC1 or IP3R3, suggesting that reduced co-localization and
interaction measured by confocal microscopy and PLA in R6/1 striatal
cultures involve loss of ER-mitochondrial contacts.
3.3. Loss of ER-mitochondrial contacts can be reverted by preventing
aberrant mitochondrial fission in R6/1 striatal cultures
Increased Drp1-mediated mitochondrial fission could be responsible
of reducing ER-mitochondria contacts in R6/1 striatal neurons. To test
this hypothesis, we analyzed in R6/1 neurons whether reversion of
mitochondrial fragmentation by Mdivi-1 treatment was also accom-
panied by a rescue of ER-mitochondria tethers. As expected, R6/1
neurons showed fragmented mitochondria along with a significant de-
crease in ER-mitochondria contacts as supported by a lower Mander's
co-localization coefficient (Fig. 3). Treatment with Mdivi-1 completely
restored ER and mitochondria contacts, showing R6/1-treated neurons
similar values to those found in WT neurons (Fig. 3). These findings
indicate an important contribution of aberrant mitochondrial frag-
mentation to disrupted ER-mitochondrial contacts in R6/1 striatal
cultured neurons.
3.4. Increased mitochondria superoxide production can also be reverted by
inhibition of mitochondrial fission in R6/1 striatal cultures
Since mitochondrial function is dependent on their intact structure,
we next analyzed in R6/1 striatal neurons whether Mdivi-1-mediated
normalization of the mitochondrial network was also associated with a
functional recovery of the mitochondria. To this aim, mitochondrial
superoxide levels were determined by MitoSox Red staining (Fig. 4). A
significant two-fold increase in mitochondrial superoxide levels was
found in R6/1 compared to WT striatal neurons. Interestingly, inhibi-
tion of mitochondrial fission by treatment with Mdivi-1 returned
mitochondrial superoxide to levels comparable to WT. These results
suggest that disruption of mitochondria dynamics due to excessive
mitochondria fission likely impact on striatal oxidative stress status in
R6/1 striatal neuronal cultures.
3.5. Specific reduction of MAMs proteins in the striatum of two different HD
mice and in HD human brain
The contacts between ER and mitochondria (MAMs) depend on
complementary membrane proteins that tether both organelles at spe-
cific sites (Rizzuto et al., 1998; Csordás et al., 2006). Even if no changes
in some MAMs proteins have been found in R6/1 striatal cultures (Fig.
S3B), we cannot discard deficiencies in MAMs protein expression in R6/
1 brain tissue. Therefore, the expression of the glucose-regulated pro-
tein 75 (Grp75), the isoform 3 of the inositol triphosphate receptor
(IP3R3), and mitofusin 2 (Mfn2), were determined in total lysates ob-
tained from the striatum of WT and R6/1 mice at the age of 8, 12, 20
and 30weeks by Western blot (Fig. 5A). To notice that at 12 weeks of
age, R6/1 mice start to manifest motor coordination symptoms eval-
uated by the rotarod test (Anglada-Huguet et al., 2016). Compared with
WT mice, a significant decrease in Grp75 levels was observed in R6/1
mice at 12 and 20weeks of age, a reduction that was no evident at late
disease stages (30 weeks). By contrast, when IP3R3 levels were ana-
lyzed, a significant decline was detected in R6/1 mice by 12weeks of
age, showing at 20 and 30weeks a similar reduction. Finally, Mnf2
exhibited a small but significant decrease at the age of 20 weeks
without significant differences at the other analyzed ages. Since re-
duction of MAMs proteins in R6/1 mice may come together with
changes in ER protein levels, we next analyzed the protein expression of
the ER chaperones calnexin and calreticulin, the ER Ca2+ sensor Stim1
and the structural ER protein Nogo (Fig. S4). Total and ER membrane
fractions were obtained from WT and R6/1 at the age of 12 weeks and
Western blot analysis performed. All analyzed proteins either in total
(Fig. S4A) or ER fractions (Fig. S4B) showed similar levels between the
two genotypes, suggesting no major ER protein alterations in R6/1
striatum.
Comparable data regarding MAMs protein levels were obtained
when a different HD mouse model, the knock-in mutant HdhQ7/Q111
mice with a slow progression of the HD pathology (Wheeler et al.,
1999), was analyzed (Fig. 5B). As in R6/1 mice, the striatal levels of
Grp75 were found significantly decreased in HdhQ7/Q111 mutant mice
compared with HdhQ7/Q7 wild type mice at 9months of age, with a
trend to decrease at 13months and no significant differences at
18months. For IP3R3, there was a sustained reduction beginning at
9months of age while for Mfn2, a decrease only at 9months was de-
tected. Next, we investigated the levels of these MAMs proteins in
postmortem brain tissue from the putamen of healthy and HD in-
dividuals (Fig. 6). Quantitative immunoblot analysis revealed a sig-
nificant decrease of all analyzed proteins in the putamen of HD patients
compared with controls (Grp75; control: 100 ± 10.36, HD:
56.48 ± 14.39; p= .0407, IP3R3; control: 100 ± 1253, HD:
89.91 ± 2535; p= .0062 and Mfn2; control: 100 ± 69.61, HD:
69.8 ± 10.07; p= .0407). Altogether, these results indicate that
aberrant expression of MAMs proteins may contribute to disruption of
ER-mitochondria contacts in HD mice striatum.
Fig. 7. ER-mitochondrial Ca2+ transfer is altered in R6/1 primary striatal neurons. Primary striatal neurons loaded with Fluo4 (5 μM) and TMRM (20 nM) were
stimulated with TG (0.5 μM) and FCCP (2 μM). Bar histograms showing fluorescence folds change of Fluo4 or TMRM at basal conditions (A) and after thapsigargin (B)
or FCCP (C) exposure. (D) Representative Fluo4 and TMRM fluorescence traces from WT (black) and R6/1 (red) individual striatal neurons following thapsigargin
(TG) and FCCP stimulation. For single-cell imaging studies, data represent mean ± SEM of 6 independent experiments. ⁎p < .05, ⁎⁎p < .01, ⁎⁎⁎p < .001 vs WT as
determined by unpaired Student's t-test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Our previous findings showing mitochondrial fission along with loss
of ER-mitochondria contacts in R6/1 striatal cultures and altered ex-
pression of MAMs proteins in the striatum of HD mouse models and HD
human brain may explain the specific vulnerability of this brain region
to mutant huntingtin toxicity. To support this idea, we next analyzed
MAMs proteins levels in the cortex (Fig. S5) and hippocampus (Fig. S6)
of both R6/1 and HdhQ7/Q111 mutant mice as well as in HD human
cortex (Fig. S7A) and hippocampus (Fig. S7B). Although, a significant
change for Grp75 levels was found in the cortex of 12 weeks-old R6/1
mice (Fig. S5A), no major changes were detected for protein (Grp75,
IP3R3, Mfn2) nor for brain region (cortex and hippocampus) in HD
versus WT or control samples, which underline the relevance of these
changes in deregulating ER-mitochondria crosstalk particularly in the
striatum.
3.6. Impaired ER-mitochondria Ca2+ transfer in R6/1 striatal cultures
Considering the observed reduction of ER and mitochondria con-
tacts in R6/1 striatal cultures, we wondered whether Ca2+ exchange
between these two compartments could also be altered and contribute
to disruption of Ca2+ homeostasis. To this aim, the levels of in-
tracellular Ca2+ (Cai2+) and the mitochondrial membrane potential
(ΔΨm) were simultaneously monitored using Fluo4 and TMRM, re-
spectively. No differences between genotypes in basal Cai2+ and ΔΨm
were observed (Fig. 7A). Next, Ca2+ release from the ER was induced
by using thapsigargin (TG), which depletes ER Ca2+ stores inhibiting
sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) activity. We found
that TG treatment induced a higher increase in Cai2+ concentration in
R6/1 striatal neurons than in WT neurons (~ 50% increase; p < .05;
Fig. 7B). This phenomenon could be due to reduced mitochondria Ca2+
uptake by R6/1 neurons, since the robust increase in Cai2+ was asso-
ciated with a slighter depolarization of the ΔΨm compared to WT
neurons (~ 20% less decrease; p < .05; Fig. 7B) as indicated by TMRM
fluorescence. Next, to demonstrate that R6/1 striatal neurons exhibit
mitochondria Ca2+ uptake deficits, primary neuronal cultures were
treated with FCCP, an uncoupler of oxidative phosphorylation that
collapses the mitochondrial membrane potential, to induce a maximal
depolarization. According to our hypothesis, the increase on Cai2+ in-
duced by FCCP-mediated mitochondrial depolarization was lower in
R6/1 neurons compared to WT neurons (~ 25% less increase;
p < .001; Fig. 7C) as well as the depolarization of the ΔΨm (~ 25%
less decrease; p < .001; Fig. 7C). Representative traces of individual
cells are shown in Fig. 7D.
Overall, these results suggest that the reduction on mitochondrial
Ca2+ retention could be due to altered ER-mitochondrial Ca2+ transfer
and therefore with disturbances in ER-mitochondria contacts. In
agreement with this hypothesis, treatment of R6/1 neurons with Mdivi-
1 prevented the increase in Cai2+ levels and the decrease in mi-
tochondrial membrane potential following TG incubation (Fig. 8B).
Similarly, mitochondria Ca2+ uptake disturbances, manifested as re-
duced Cai2+ concentration and TMRM fluorescence in depolarized
FCCP conditions, were also ameliorated in R6/1-treated Mdivi-1 neu-
rons (Fig. 8C). Notice that Mdivi-1 treatment did not alter Basal Fluo4
or TMRM fluorescence (Fig. 8A). Altogether, these findings support the
view that altered ER-mitochondria tethering underlies Ca2+ home-
ostasis defects in HD striatum.
4. Discussion
Disruption of mitochondrial function and calcium (Ca2+) home-
ostasis are well-recognized pathological features of HD that contribute
to the preferential degeneration of the striatum in this disorder
(Browne, 2008; Lezi and Swerdlow, 2012). However, little is known on
how changes in mitochondria dynamics induced by mutant huntingtin
may affect Ca2+ mitochondrial handling and mitochondrial oxidative
stress. In this study, we provide evidence showing that deregulation of
mitochondrial fission events may have a detrimental role in HD striatal
pathology by (1) enacting loss of ER-mitochondria contacts with the
consequent disturbances in intracellular Ca2+ homeostasis and (2) fa-
voring mitochondrial production of superoxide.
Mitochondrial dynamics is a crucial event that determines mi-
tochondrial morphology and size but also regulates mitochondrial dis-
tribution and function (Chan, 2006). Previous results from our labora-
tory and others have reported that this process is disrupted in several
HD cellular and mouse models revealing increased mitochondrial
fragmentation and therefore an imbalance towards mitochondrial fis-
sion events (Reddy, 2014; Cherubini et al., 2015; Guo et al., 2013). In
line with this evidence, in this study we have shown impaired mi-
tochondrial dynamics, evidenced by a prominent mitochondrial frag-
mentation and disruption of the mitochondrial network in the striatum
but not in the cortex or hippocampus of exon-1 R6/1 transgenic mice.
This excessive mitochondrial fission was Drp1-dependent since pre-
treatment with Mdvi-1, a well-known inhibitor of mitochondrial fission
that blocks GTPase Drp1 activity (Cassidy-Stone et al., 2008) com-
pletely restored mitochondrial shape and network parameters. Indeed
and according with aberrant Drp1 activity, a trend increase tendency in
Drp1 tetrameric protein forms and Drp1 mRNA levels was found in R6/
1 striatal primary cultures when compared with WT cultures. These
findings are in agreement with previous studies from our group and
others showing increased Drp1 activity in HD striatal neurons as well as
a protective effect of Mdvi-1 against mutant huntingtin induced striatal
neuropathology (Cherubini et al., 2015; Shirendeb et al., 2011;
Manczak and Hemachandra Reddy, 2015).
The increase in mitochondrial fragmentation that we have reported
in HD striatum, could negatively interferes with neuronal function at
different levels. First, inhibition of mitochondrial fusion has been as-
sociated with impaired Oxidative Phosphorylation (OXPHOS) and ROS
production in different cellular types (Liesa and Shirihai, 2013) stres-
sing the idea that mitochondrial function is strongly dependent on
preserved mitochondria structure. Accordingly, we have observed that
the increase in mitochondria superoxide production in R6/1 striatal
cultures can be reversed after normalization of the mitochondria net-
work by Mdvi-1 treatment. Similarly, Manzcak and colleagues have
described a beneficial effect of Mdvi-1 in reducing mitochondrial fis-
sion, OXPHOS activity and free radicals generation in HD cellular
models (Manczak and Hemachandra Reddy, 2015). Second, the pro-
pensity of mitochondria to undergo fragmentation in HD striatum could
result in the disruption of ER-mitochondria contacts negatively acting
Fig. 8. Mdivi-1 treatment restores ER-mitochondrial Ca2+ transfer in R6/1 primary striatal neurons. Primary striatal neurons treated with vehicle (DMSO) or Mdivi-1
(25 μM) and successively loaded with Fluo4 (5 μM) and TMRM (20 nM) were stimulated with TG (0.5 μM) and FCCP (2 μM). Bar histograms showing fluorescence
folds change of Fluo4 or TMRM at basal conditions (A) and after thapsigargin (B) or FCCP (C) exposure. (D) Representative Fluo4 and TMRM fluorescence traces from
WT (black), R6/1 (red) and Mdivi-1-treated R6/1 (green) individual striatal neurons following thapsigargin (TG) and FCCP stimulation. For single-cell imaging
studies, data represent mean ± SEM of 3 independent experiments. ⁎p < .05, ⁎⁎⁎p < .001 vs WT and #p < .05, ##p < .01 vs vehicle-treated R6/1 as determined
by One-way ANOVA analysis with Tukey's multiple comparison test.
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on the role of mitochondria in Ca2+ buffering. According with this idea,
we found in R6/1 striatal neurons an important decrease in ER-mi-
tochondrial apposition evidenced by a loss of co-localization between
both organelles. Again, restoration of the mitochondrial network by
Mdivi-1 reversed the loss of ER-mitochondria contacts, supporting the
idea that increased mitochondrial fission is critically involved in the
disruption of ER-mitochondria tethering in HD striatum. Similarly,
parkin dysfunction in Parkinson's disease (PD) models has been asso-
ciated with altered mitochondrial fragmentation and defective ER-mi-
tochondria contacts with the subsequent alteration in mitochondrial
Ca2+ uptake (Calì et al., 2013a; Zheng et al., 2017; Celardo et al.,
2016). Likewise, reduction of PINK1 expression in human dopaminergic
neuroblastoma cells, impairs mitochondria fusion and mitochondria
motility altering ER-mitochondria association (Parrado-Fernández
et al., 2018).
Nevertheless, besides the disruption of the mitochondrial network
other mechanisms could be involved in the reduction of ER-mitochon-
dria contacts in HD striatum. MAMs contain specific proteins that fa-
cilitate the physical association between the ER and mitochondria.
Therefore, alteration in the expression of MAM-resident proteins may
also contribute to aberrant ER-mitochondria communication.
Supporting this hypothesis, we found in the striatum but not in the
cortex or hippocampus of two different HD mouse models and in human
HD striatum a significant reduction in ER-anchored IP3 receptor 3 and
in chaperone Grp75 protein levels. A decrease in mitofusin-2 was only
observed in HD human putamen. The fact that the reduction of MAM's
proteins in striata of HD mouse models runs in parallel to the behavioral
disturbances, points at ER-mitochondria loss of contacts as a critical
contributor rather than a primary cause of striatal vulnerability.
Nevertheless, the decrease in MAMs proteins can be detected at early-
middle disease stages suggesting that this reduction is not just a con-
sequence of striatal dysfunction but a factor in HD progression.
Perturbations in several proteins of the ER-mitochondria interface have
also been reported in other neurodegenerative disorders either enhan-
cing or decreasing ER-mitochondria juxtaposition. Thus, up-regulation
of several MAM-associated proteins along with increased function of
MAM and ER-mitochondria interaction has been observed both in
Alzheimer's disease (AD) murine models and in AD human fibroblasts
(Area-Gomez et al., 2012; Hedskog et al., 2013). In contrast, different
Amyotrophic lateral sclerosis or PD-causing mutations have been as-
sociated with either higher or lower ER-mitochondria contacts by al-
tering expression or binding between MAM-resident proteins
(Erpapazoglou et al., 2017).
So far, these findings suggest that direct communication between
mitochondria and ER is compromised in HD. Given that a major func-
tion of ER-mitochondria contacts is to transfer Ca2+ from ER stores to
mitochondria (Rizzuto et al., 1998) and given the reported mitochon-
drial Ca2+ mishandling in HD pathology (Milakovic et al., 2006;
Rosenstock et al., 2010; Naia et al., 2017), we hypothesize that dis-
ruption of ER-mitochondria tethering will contribute to Ca2+ dish-
omeostasis in HD striatum. In agreement with this hypothesis, we de-
monstrated in HD striatal neurons that induction of Ca2+ release from
the ER produces an immediate increase in intracellular Ca2+ (Cai2+)
associated with a low mitochondrial depolarization, which is suggestive
of defective mitochondrial Ca2+ uptake. These results prompted us to
propose a new but not exclusive mechanism for mitochondrial Ca2+
mishandling in HD, which differs from some studies previously reported
(Milakovic et al., 2006; Choo et al., 2004). These studies attribute the
aberrant increase in Cai2+ to the enhanced mitochondrial sensitivity to
Ca2+ loads. However, the recovery of the mitochondrial Ca2+ capacity
and the inhibition of mitochondrial permeability transition pore (PTP)
induction failed to ameliorate either the behavioral or the neuro-
pathological features of the disease (Perry et al., 2010). Other studies
have reported an age-dependent increase in the Ca2+ loading capacity
of striatal mitochondria (Brustovetsky et al., 2005) or even no changes
(Oliveira et al., 2007). These discrepancies may be the result of dif-
ferences in the analyzed disease stage or the use of isolated mi-
tochondria versus intact striatal neurons. Our results obtained in an
appropriate neuronal context, that is HD-derived striatal neurons,
suggest that Ca2+ dishomeostasis in HD could depend not only on in-
trinsic mitochondrial Ca2+ buffering capacity but also on MAMs in-
tegrity. Supporting this view, treatment of R6/1 mutant huntingtin
striatal neurons with the Drp1 inhibitor Mdivi-1, not only restored the
loss of ER-mitochondria contacts but also the ER-mitochondria Ca2+
transfer improving Ca2+ homeostasis defects. Indeed, compelling evi-
dence have highlighted the importance of a proper distance between
the ER and mitochondria to transfer Ca2+ efficiently between these two
organelles (Csordás et al., 2010; Shin and Muallem, 2010). Thus, the
gap between ER and mitochondria generated by aberrant mitochondrial
fragmentation, could be sufficient to isolate mitochondria from the ER-
Ca2+ leakage, impeding properly mitochondrial Ca2+ handling in HD
striatum.
5. Conclusion
In sum, considering the critical role played by mitochondrial Ca2+
in the modulation of numerous physiological responses, particularly in
neurons (Brini et al., 2014), the disruption of ER-mitochondria tethers
in the HD striatum by either increased mitochondria fission or loss of
MAM-resident proteins could play a pivotal role on Ca2+ dish-
omeostasis and contribute to striatal dysfunction and degeneration in
HD.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2020.104741.
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